Oragenics
高管
查看带有其 10 名主要高管的组织结构图
Oragenics 搜索最多的简介
- Charles Pope, Interim Chief Executive Officer and Chairman of the ...
- Alan Dunton, Director
- Kimberly Murphy, Director
高管在Oragenics变化
- James Kelly已作为Chief Medical Officer加入公司 (新闻发布的2024三月19号).
- Charles Pope 曾任 Chairman of the Board, 现升职为 Interim Chief Executive Officer and Chairman of the Board (新闻发布的2024二月13号).
- John Gandolfo已作为Director加入公司 (新闻发布的2023十月18号).
创建提醒
跟踪 Oragenics 的高管变动
生物技术
Oragenics 拥有 2,281 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Endeavor BioMedicines 刚刚宣布为 132 筹款数百万美元。 (公布2024四月25号).
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
生物技术 行业的其他推荐联系人
消息
Oragenics 的最新新闻稿
- Oragenics, Inc. Files 10K and Provides Company Update :: Oragenics, Inc. (OGEN)
- Press Releases :: Oragenics, Inc. (OGEN)
- Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion :: Oragenics, Inc. (OGEN)
- Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion :: Oragenics, Inc. (OGEN)
- Oragenics Announces Proposed Public Offering :: Oragenics, Inc. (OGEN)
- Oragenics Announces Pricing of Public Offering :: Oragenics, Inc. (OGEN)
- Oragenics Announces Closing of Public Offering :: Oragenics, Inc. (OGEN)
- Oragenics, Inc. Announces Leadership Transition :: Oragenics, Inc. (OGEN)
- Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion :: Oragenics, Inc. (OGEN)
- Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement :: Oragenics, Inc. (OGEN)
- View more press releases Close
关于 Oragenics 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Charles Pope 
